Rare diseases
Investigational molecules
Locations
Back to France479 clinical trials in Besançon, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
FranceStudy of Retifanlimab Alone and in Combination with Drug Therapy for Adults with Advanced or Metastatic Endometrial Cancer Who Have Not Responded to Platinum Chemotherapy
FranceStudy Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer
FranceStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
FranceStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
FranceStudy of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis
FranceStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
FranceStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
FranceStudy of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant
FranceStudy on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, colorectal cancer, and melanoma treatments. Studies evaluate novel therapeutic combinations and maintenance strategies.
Several trials are exploring breakthrough treatments for various types of carcinomas and investigating new therapeutic pathways.
Research focusing on multiple sclerosis and essential tremor. Studies evaluate treatment de-escalation strategies and novel therapeutic compounds.
Trials aim to improve quality of life and develop more effective treatment approaches for neurological conditions.
Investigations into heart failure prevention and treatments for elderly patients with coronary conditions. Studies examine innovative drug combinations and antiplatelet therapy strategies.
Research focuses on improving cardiovascular outcomes and developing targeted preventive strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
